Mount Sinai Innovation Partners
VC Fund
New York, United States
Mount Sinai Innovation Partners is a VC fund in New York focused on Health Care and Medical Device. MSIP is responsible for driving the real-world application and commercialization of Mount Sinai discoveries and inventions, and the development of research partnerships with industry. Their aim is to translate discoveries and inventions into health care products and services that benefit patients and society. MSIP is accountable for the fullspectrum of commercialization activities required to bring Mount Sinai inventions to life. These activities include evaluating, patenting, marketing and licensing new technologies building research, collaborations and partnerships with commercial and nonprofit entities, material transfer and confidentiality, coaching innovators to advance commercially-relevant translational discoveries, and actively fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities.
- Total investments:
- 21
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Mount Sinai Innovation Partners invests in
Stages Mount Sinai Innovation Partners invests in
Countries Mount Sinai Innovation Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Neubert
|
|||
Dov Shamir
|
|||
2 more contacts available
Investment Focus
Industry
- Health Care 8 (38%)
- Medical Device 7 (33%)
- Medical 6 (29%)
- Robotics 2 (10%)
- Software 2 (10%)
Stage
- Funding Round 7 (33%)
- Seed 6 (29%)
- Pre-Seed 5 (24%)
- Grant 1 (5%)
- Venture - Series Unknown 1 (5%)
Country
- United States 9 (43%)
- Singapore 2 (10%)
- Canada 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
David Neubert
Attending Emergency Physician
|
Attending Emergency Physician | Total investments: 0 | Find email | |
|
Dov Shamir
Head of Elementa Labs
|
Head of Elementa Labs | Total investments: 18 | Find email | |
Lisa Wisniewski
Executive in Residence
|
Executive in Residence | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NousQ Pte Ltd
|
NousQ is the inventor of CLiKX, the world’s first handheld robotic device with sensors to treat glue ears. Otitis Media with Effusion (or “glue ears”) is the foremost reason why children visit a doctor. It affects the hearing of millions of children worldwide annually. When conservative treatments do not work, surgery is required to place a tinyventilation tube to drain the fluid from the middle ear. Given the invasive nature of the current surgery, an operating theatre, general anaesthesia and a large non-portable surgical microscope is needed. With CLiKX, we are able to move the surgery out of the operating theatre into the clinic using local anaesthesia and without the large surgical microscope. This drastically reduces treatment time, procedure costs and the long waiting time for surgery. | Feb 01, 2024 | |
AvoMD
|
AvoMD is a no-code software platform that transforms clinical content – guidelines, algorithms, pathways, and checklists - into "virtual clinical consults" available instantly at the point-of-care on standalone web/mobile apps and in the EHR. Leading societies and health systems partner with AvoMD to transform authoritative clinicalexpertise into instant expert guidance at the bedside. Studies show that AvoMD improves outcomes while saving clinicians ~50% of their time in accessing and using information at the point-of-care. | $5M / Seed / Jun 23, 2023 | |
Jelikalite
|
Jelikalite creates medical equipment for kids with autism spectrum disorders. They emphasize using non-invasive innovative methods to promote the brain health of children. It is a wearable medical device. It combines infrared light, sensors, an AI personalization platform, and non-invasive brain stimulation. | Seed / Feb 01, 2023 | |
|
Jelikalite
|
Jelikalite creates medical equipment for kids with autism spectrum disorders. They emphasize using non-invasive innovative methods to promote the brain health of children. It is a wearable medical device. It combines infrared light, sensors, an AI personalization platform, and non-invasive brain stimulation. | Jan 23, 2023 | |
Memoria
|
Memoria is the end-to-end platform enabling families to organize, book, and finance a loved one’s funeral. | Jan 23, 2023 | |
EmpiricaLab
|
EmpiricaLab is a last-mile training, team-centric authoring, and knowledge platform focused on enabling peer learning for healthcare teams. | Jan 23, 2023 | |
|
Memoria
|
Memoria is the end-to-end platform enabling families to organize, book, and finance a loved one’s funeral. | Pre-Seed / Jan 23, 2023 | |
|
EmpiricaLab
|
EmpiricaLab is a last-mile training, team-centric authoring, and knowledge platform focused on enabling peer learning for healthcare teams. | Pre-Seed / Jan 23, 2023 | |
A.D.A.M.
|
A.D.A.M. (Advanced Development of Additive Manufacturing) is a biotech company that provides 3D-bioprinting services on demand. A.D.A.M. uses its proprietary 3D-printing technology and patented materials to manufacture bioresorbable and biodegradable patient-specific implants (primarily, bone implants).By designing and building an on-demandtissue manufacturing solution, we have been pioneering this technology as a service model to effectively address a complex problem. The business model will allow patients to have their tissue modelled – using the MRI/CAT scans stored on the digital platform – and, subsequently, 3D-printed and implanted in certified clinics.We reached our main achievement to date in August, as the FDA responded to our Q-Sub (Pre-Submission) confirming our 510(k) regulatory path eligibility. This response means that no human trials and required and a decrease in time to market from 5 years to 1.5-2 years. Additionally, we have been accepted to join Technology Incubation Program at University of Connecticut in Farmington, CT. We have just moved our main office there as TIP offers state of the art research facilities and resources to its member companies. Our intention is to complete the required animal studies there. Finally, we have secured our lead investor for the upcoming Series A round. | Apr 01, 2022 | |
HelpWear
|
HelpWear is striving to achieve better at-home healthcare by developing affordable and accessible products for patients all around the world. HelpWear’s focus is clinical need driven innovation, designing solutions to not only what a patient would need, but from a clinical perspective, to what the healthcare system requires as well. | Seed / Apr 01, 2022 | |
| See all 21 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Mount Sinai Innovation Partners invest in?
Mount Sinai Innovation Partners invests primarily in Health Care, Medical Device and Medical startups, most often at Funding Round and Seed stage. Most of the 21 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mount Sinai Innovation Partners?
Public channels for Mount Sinai Innovation Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mount Sinai Innovation Partners?
The team at Mount Sinai Innovation Partners includes David Neubert (Attending Emergency Physician), Dov Shamir (Head of Elementa Labs) and Lisa Wisniewski (Executive in Residence). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
